BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 26228654)

  • 1. De novo hepatic steatosis drives atherogenic risk in liver transplantation recipients.
    Idowu MO; Chhatrala R; Siddiqui MB; Driscoll C; Stravitz RT; Sanyal AJ; Bhati C; Sargeant C; Luketic VA; Sterling RK; Contos M; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 Nov; 21(11):1395-402. PubMed ID: 26228654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of serum atherogenic risk in liver transplant recipients: Role of lipoproteins and metabolic and inflammatory markers.
    Chhatrala R; Siddiqui MB; Stravitz RT; Driscoll C; Sanyal A; Sargeant C; Luketic V; Sharma A; Sterling R; Matherly S; Puri P; Siddiqui MS
    Liver Transpl; 2015 May; 21(5):623-30. PubMed ID: 25762084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis.
    Siddiqui MS; Sterling RK; Luketic VA; Puri P; Stravitz RT; Bouneva I; Boyett S; Fuchs M; Sargeant C; Warnick GR; Grami S; Sanyal AJ
    Gastroenterology; 2013 Dec; 145(6):1271-9.e1-3. PubMed ID: 23973920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic Steatosis and Insulin Resistance, But Not Steatohepatitis, Promote Atherogenic Dyslipidemia in NAFLD.
    Bril F; Sninsky JJ; Baca AM; Superko HR; Portillo Sanchez P; Biernacki D; Maximos M; Lomonaco R; Orsak B; Suman A; Weber MH; McPhaul MJ; Cusi K
    J Clin Endocrinol Metab; 2016 Feb; 101(2):644-52. PubMed ID: 26672634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Dense Low-Density Lipoprotein Cholesterol Predicts Cardiovascular Events in Liver Transplant Recipients.
    Siddiqui MB; Arshad T; Patel S; Lee E; Albhaisi S; Sanyal AJ; Stravitz RT; Driscoll C; Sterling RK; Reichman T; Bhati C; Siddiqui MS
    Hepatology; 2019 Jul; 70(1):98-107. PubMed ID: 30672598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of hepatic steatosis to atherogenic dyslipidemia.
    Makadia SS; Blaha M; Keenan T; Ndumele C; Jones S; DeFilippis A; Martin S; Kohli P; Conceicao R; Carvalho J; Nasir K; Blumenthal R; Santos RD
    Am J Cardiol; 2013 Nov; 112(10):1599-604. PubMed ID: 24012029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atherogenic Lipoprotein Determinants of Cardiovascular Disease and Residual Risk Among Individuals With Low Low-Density Lipoprotein Cholesterol.
    Lawler PR; Akinkuolie AO; Chu AY; Shah SH; Kraus WE; Craig D; Padmanabhan L; Glynn RJ; Ridker PM; Chasman DI; Mora S
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28733430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of nonalcoholic fatty liver disease and progression to cirrhosis are associated with atherogenic lipoprotein profile.
    Siddiqui MS; Fuchs M; Idowu MO; Luketic VA; Boyett S; Sargeant C; Stravitz RT; Puri P; Matherly S; Sterling RK; Contos M; Sanyal AJ
    Clin Gastroenterol Hepatol; 2015 May; 13(5):1000-8.e3. PubMed ID: 25311381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-alcoholic fatty liver disease in liver transplant recipients: another story of "seed and soil".
    Dumortier J; Giostra E; Belbouab S; Morard I; Guillaud O; Spahr L; Boillot O; Rubbia-Brandt L; Scoazec JY; Hadengue A
    Am J Gastroenterol; 2010 Mar; 105(3):613-20. PubMed ID: 20040915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
    Ikezaki H; Lim E; Cupples LA; Liu CT; Asztalos BF; Schaefer EJ
    J Am Heart Assoc; 2021 Feb; 10(5):e019140. PubMed ID: 33586462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of hepatic steatosis (fatty liver) on severity and composition of dyslipidemia in type 2 diabetes.
    Toledo FG; Sniderman AD; Kelley DE
    Diabetes Care; 2006 Aug; 29(8):1845-50. PubMed ID: 16873790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome after pediatric liver transplantation.
    Kosola S; Lampela H; Makisalo H; Lohi J; Arola J; Jalanko H; Pakarinen M
    Liver Transpl; 2014 Oct; 20(10):1185-92. PubMed ID: 24923737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study.
    Hoogeveen RC; Gaubatz JW; Sun W; Dodge RC; Crosby JR; Jiang J; Couper D; Virani SS; Kathiresan S; Boerwinkle E; Ballantyne CM
    Arterioscler Thromb Vasc Biol; 2014 May; 34(5):1069-77. PubMed ID: 24558110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic lipase activity is increased in non-alcoholic fatty liver disease beyond insulin resistance.
    Miksztowicz V; Lucero D; Zago V; Cacciagiú L; Lopez G; Gonzalez Ballerga E; Sordá J; Fassio E; Schreier L; Berg G
    Diabetes Metab Res Rev; 2012 Sep; 28(6):535-41. PubMed ID: 22539458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-Rich Lipoprotein Cholesterol, Small Dense LDL Cholesterol, and Incident Cardiovascular Disease.
    Duran EK; Aday AW; Cook NR; Buring JE; Ridker PM; Pradhan AD
    J Am Coll Cardiol; 2020 May; 75(17):2122-2135. PubMed ID: 32354380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of liver injury and atherogenic lipid profile in children with nonalcoholic fatty liver disease.
    Nobili V; Alkhouri N; Bartuli A; Manco M; Lopez R; Alisi A; Feldstein AE
    Pediatr Res; 2010 Jun; 67(6):665-70. PubMed ID: 20496475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of low-density and high-density lipoprotein subclasses in pediatric renal transplant recipients.
    Zeljkovic A; Vekic J; Spasojevic-Kalimanovska V; Jelic-Ivanovic Z; Peco-Antic A; Kostic M; Vasic D; Spasic S
    Transpl Int; 2011 Nov; 24(11):1094-102. PubMed ID: 21848901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.